Overview
TONIX Pharmaceuticals Holding Corp. (OTCQB: TNXP)TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system. The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX reformulates known pharmaceutical agents to design drugs with optimal safety, efficacy and predictability. Its most advanced product candidate, TNX-102 SL, is in development for fibromyalgia and PTSD. |
||||||
Upcoming EventsThere are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases. |
Share StatisticsOutstanding: 2,197,490 |
|||||
Recent News |
||||||
Quick Links
|
||||||
Investor RelationsDian Griesel Inc. |
Transfer AgentvStock Transfer |
AuditorsEisnerAmper LLP S&P Market AccessClick Here to see our profile on Standard & Poor's. |
||||
